Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- Could Myeloma Induction Cure???
Could Myeloma Induction Cure???
Could myeloma induction cure? To put it another way, could prehabilitation and enhancing the MM patient’s gut microbiome enhance the efficacy of treatment while reducing the severity of side effects?
The research linked below indicates that this is possible.
If you’re a newly diagnosed MM patient, why isn’t your oncologist recommending that you spend a couple of weeks prehabilitating and eating foods to enhance your gut microbiome before you begin your induction therapy?
IMS 2025 Highlight: Myeloma Treatment Is Changing Fast | Mohamad Mohty, MD, PhD | #IMS2025
I believe that board-certified MM specialists are smart, experienced medical doctors who know a helluva lot about MM. The problem, in my experience, is that these people, generally, are too focused on treating myeloma with conventional therapies, aka chemotherapy (all-inclusive definition),
I think drug companies and their financial influence cause oncology to focus on conventional treatments rather than on cancer patients.
In the video above, Dr. Mohty is practically giddy, citing the percentage of NDMM patients achieving MRD negativity with induction therapy. I agree with Dr. Mohty. Induction therapy has come a long way since I underwent VAD therapy in 1995.
But prehabilitation and the gut microbiome’s effect on newly diagnosed cancer patients have been studied for years. I believe that thousands of NDMM patients have had to endure shorter remissions and more extreme side effects because of conventional oncology’s lack of vision.
A college friend was recently diagnosed with MM. I wasn’t in the room with Moe (not his real name) when he talked to his oncologist, but I’ll bet that the oncologist didn’t mention prehabilitation or Moe’s gut microbiome.
Are you a newly diagnosed MM patient? Are you curious about evidence-based non-conventional therapies? Scroll down the page, post a question or comment, and I will reply to you ASAP.
Good luck,
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
Prehabilitation is the Gateway to Better Functional Outcomes for Individuals with Cancer
Abstract
Prehabilitation is a clinical model that introduces components of rehabilitation to patients prior to undergoing intensive medical interventions, such as surgery, in order to optimize function and improve tolerability to the intervention. Cancer care introduces a continuum of sequential or concurrent intensive anti-neoplastic medical interventions that are known to be detrimental to a patient’s function.
Prehabilitation evidence has grown across several areas of oncology care delivery demonstrating that a multi-modal rehabilitative intervention, delivered prior to oncology-direct therapies, leads to better functional outcomes and improves important endpoints associated with surgery and cancer treatment.
This commentary article provides a brief history of the emergence of prehabilitation in cancer care delivery, reviews the current evidence base and guidelines for prehabilitation, and offers insights for future implementation of this model as a standard in oncology care.
A prehabilitation program is an optimal starting point for most patients undergoing anti-neoplastic therapy, as it serves as a gateway to improving functional outcomes throughout the cancer continuum.
Future research in prehabilitation should aim to reach beyond measuring functional outcomes and to explore the impact of this model on important disease treatment endpoints such as tumor response to oncology-directed treatment, impact on treatment-related toxicities, and disease progression…
Introduction
Cancer prehabilitation is defined as a “process in the cancer continuum of care that occurs between the time of cancer diagnosis and the beginning of acute treatment and includes physical and psychological assessments that establish a baseline functional level, identify impairments, and provide interventions that promote physical and psychological health to reduce the incidence and/or severity of future impairments.”1
Prehabilitation, as a model of care in rehabilitation, evolved from getting soldiers physically and emotionally ready for combat.2 Physicians recognized that helping patients get stronger before an upcoming stressor, such as surgery, would likely help to decrease morbidity and mortality. Evidence of prehabilitation models is found across medicine in orthopedics and sports medicine, cardiac care, as well as cancer. Thus, for decades prehabilitation has been documented in the medical literature with more exponential growth recently focused on cancer. (Figure 1a and 1b)…
Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
Abstract
The gut commensal microbes modulate human immunity and metabolism through the production of a large number of metabolites, which act as signaling molecules and substrates of metabolic reactions in a diverse range of biological processes. There is a growing appreciation for the importance of immunometabolic mechanisms of the host-gut microbiota interactions in various malignant tumors. Emerging studies have suggested intestinal microbiota contributes to the progression of multiple myeloma.
In this review, we summarized the current understanding of the gut microbiome in MM progression and treatment, and the influence of alterations in gut microbiota on treatment response and treatment-related toxicity and complications in MM patients undergoing hematopoietic stem cell transplantation (HSCT).
Furthermore, we discussed the impact of gut microbiota-immune system interactions in tumor immunotherapy, focusing on tumor vaccine immunotherapy, which may be an effective approach to improve anti-myeloma efficacy…
Could myeloma induction cure Could myeloma induction cure